R
Rodolphe Jean
Researcher at Aix-Marseille University
Publications - 48
Citations - 446
Rodolphe Jean is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 44 publications receiving 330 citations.
Papers
More filters
Journal ArticleDOI
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
Raphael Cauchois,Marie Koubi,David Delarbre,Cecile Manet,Julien Carvelli,Valery Benjamin Blasco,Rodolphe Jean,Louis Fouche,Charleric Bornet,Vanessa Pauly,Karin Mazodier,Vincent Pestre,Pierre André Jarrot,Charles A. Dinarello,Gilles Kaplanski +14 more
TL;DR: It is concluded that early blockade of the IL-1 receptor is therapeutic in acute hyperinflammatory respiratory failure in COVID-19 patients.
Journal ArticleDOI
Implications cliniques de la découverte d’une hypervitaminémie B12 en médecine interne
Laurent Chiche,Rodolphe Jean,F Romain,F Roux,G. Thomas,S. Canavese,S. Branger,Jean-Robert Harlé,J.M. Durand +8 more
TL;DR: Le laboratoire referent devrait sensibiliser les cliniciens aux nombreuses orientations diagnostiques qui peuvent decouler de the decouverte d’un taux eleve de vitaminemie B12.
Journal ArticleDOI
Sarcoidosis Occurring After Solid Cancer: A Nonfortuitous Association: Report of 12 Cases and Review of the Literature.
Aurélie Grados,Mikael Ebbo,Emmanuelle Bernit,Véronique Veit,Karin Mazodier,Rodolphe Jean,Diane Coso,Thérèse Aurran-Schleinitz,Florence Broussais,Reda Bouabdallah,Gwenaelle Gravis,Anthony Gonçalves,Marc Giovaninni,Pascal Sève,Bruno Chetaille,Florence Gavet-Bongo,Thierry Weitten,Michel Pavic,Jean-Robert Harlé,Nicolas Schleinitz +19 more
TL;DR: In this paper, the authors conducted a case study from internal medicine and oncology departments for patients presenting sarcoidosis after solid cancer treatment and performed a literature review to search for patients who developed sarcoidity after cancer treatment.
Journal ArticleDOI
Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activity.
Laurent Chiche,J.-M. Cournac,Julien Mancini,Nathalie Bardin,G. Thomas,Rodolphe Jean,Nicolas Schleinitz,Gilles Kaplanski,Jean-Marc Durand,José Boucraut,Jean-Robert Harlé +10 more
TL;DR: In SLE patients without renal failure, increased FLC levels (mainly kappa) with normal kappa/lambda ratios are a common feature, and in contrast to total IgG levels, FLC concentrations correlate with biological disease activity.
Journal ArticleDOI
Serotonin reuptake inhibitors, Raynaud's phenomenon and erythromelalgia
TL;DR: This study confirmed previous case reports suggesting the usefulness of selective serotonin reuptake inhibitors (SSRIs) in the management of Raynaud's phenomenon and described for the first time two patients who experienced, when given SSRIs, disappearance of Raynauld's phenomenon but occurrence of erythromelalgia.